Proposals related to tariffs on products imported into the United States. Proposals regarding US-China trade negotiations.
2025 · 3rd Quarter (July 1 - Sep 30)
ABBOTT LABORATORIES
Filed by ABBOTT LABORATORIES.
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 20, 2025
- Income
- Not reported
- Expenses
- $1,128,989.00
- Registrant
- ABBOTT LABORATORIES
- Client
- ABBOTT LABORATORIES
- Filing UUID
- b8b762c1-111f-4a9c-a9fe-98eaaf63a5d4
- Termination date
- Not reported
Expense method: A
Literal source text
Lobbying issues and bill citations
Proposals related to third party litigation reform.
Proposals to reform domestic and international tax structures.
S. 2477/H.R. 1770 Equitable Community Access to Pharmacist Services Act. S. 2922/H.R. 7164 Advancing Research for Chronic Pain Act of 2024. Proposals related to digital health technologies and innovations. Proposals to advance policies related to effective pain management. Proposals related to the President's Emergency Plan for AIDS Relief (PEPFAR).
Literal federal measure citations: S. 2477, H.R. 1770, S. 2922, H.R. 7164
S. 1000/H.R. 1835 Saving Access to Laboratory Services Act. Proposals regarding PAMA regulations and changes to modernize and update the Clinical Laboratory Fee Schedule. Proposals related to Medicare coverage of continuous glucose monitors.
Proposals related to U.S. global health programs and pandemic preparedness. Proposals to advance global virus surveillance.
H.R. 2300 To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and for other purposes. Proposals related to access to infant formula.
Literal federal measure citations: H.R. 2300
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.